Korean Medication Algorithm Project for Bipolar Disorder: third revision

Young Sup Woo,1 Jung Goo Lee,2,3 Jong-Hyun Jeong,1 Moon-Doo Kim,4 Inki Sohn,5 Se-Hoon Shim,6 Duk-In Jon,7 Jeong Seok Seo,8 Young-Chul Shin,9 Kyung Joon Min,10 Bo-Hyun Yoon,11 Won-Myong Bahk1 1Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, South Korea; 2Depa...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Woo YS, Lee JG, Jeong JH, Kim MD, Sohn IK, Shim SH, Jon DI, Seo JS, Shin YC, Min KJ, Yoon BH, Bahk WM
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/20ebf0a4880c45368fd2c5d1fccf8833
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:20ebf0a4880c45368fd2c5d1fccf8833
record_format	dspace
spelling	oai:doaj.org-article:20ebf0a4880c45368fd2c5d1fccf88332021-12-02T03:21:50ZKorean Medication Algorithm Project for Bipolar Disorder: third revision1178-2021https://doaj.org/article/20ebf0a4880c45368fd2c5d1fccf88332015-02-01T00:00:00Zhttp://www.dovepress.com/korean-medication-algorithm-project-for-bipolar-disorder-third-revisio-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021 Young Sup Woo,1 Jung Goo Lee,2,3 Jong-Hyun Jeong,1 Moon-Doo Kim,4 Inki Sohn,5 Se-Hoon Shim,6 Duk-In Jon,7 Jeong Seok Seo,8 Young-Chul Shin,9 Kyung Joon Min,10 Bo-Hyun Yoon,11 Won-Myong Bahk1 1Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, South Korea; 2Department of Psychiatry, Inje University Haeundae Paik Hospital, Busan, South Korea;3Paik Institute for Clinical Research, Inje Univeristy, Busan, South Korea; 4Department of Psychiatry, Jeju National University Hospital, Jeju, South Korea; 5Department of Psychiatry, Keyo Hospital, Keyo Medical Foundation, Uiwang, South Korea; 6Department of Psychiatry, Soonchunhyang University Cheonan Hospital, Soonchunhyang University, Cheonan, South Korea; 7Department of Psychiatry, Sacred Heart Hospital, Hallym University, Anyang, South Korea; 8Department of Psychiatry, School of Medicine, Konkuk University, Chungju, South Korea; 9Department of Psychiatry, Kangbuk Samsung Hospital, School of Medicine, Sungkyunkwan University, Seoul, South Korea; 10Department of Psychiatry, College of Medicine, Chung-Ang University, Seoul, South Korea; 11Department of Psychiatry, Naju National Hospital, Naju, South Korea Objective: To constitute the third revision of the guidelines for the treatment of bipolar disorder issued by the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP 2014). Methods: A 56-item questionnaire was used to obtain the consensus of experts regarding pharmacological treatment strategies for the various phases of bipolar disorder and for special populations. The review committee included 110 Korean psychiatrists and 38 experts for child and adolescent psychiatry. Of the committee members, 64 general psychiatrists and 23 child and adolescent psychiatrists responded to the survey. Results: The treatment of choice (TOC) for euphoric, mixed, and psychotic mania was the combination of a mood stabilizer (MS) and an atypical antipsychotic (AAP); the TOC for acute mild depression was monotherapy with MS or AAP; and the TOC for moderate or severe depression was MS plus AAP/antidepressant. The first-line maintenance treatment following mania or depression was MS monotherapy or MS plus AAP; the first-line treatment after mania was AAP monotherapy; and the first-line treatment after depression was lamotrigine (LTG) monotherapy, LTG plus MS/AAP, or MS plus AAP plus LTG. The first-line treatment strategy for mania in children and adolescents was MS plus AAP or AAP monotherapy. For geriatric bipolar patients, the TOC for mania was AAP/MS monotherapy, and the TOC for depression was AAP plus MS or AAP monotherapy. Conclusion: The expert consensus in the KMAP-BP 2014 differed from that in previous publications; most notably, the preference for AAP was increased in the treatment of acute mania, depression, and maintenance treatment. There was increased expert preference for the use of AAP and LTG. The major limitation of the present study is that it was based on the consensus of Korean experts rather than on experimental evidence. Keywords: pharmacological treatment, treatment guideline, expert consensusWoo YSLee JGJeong JHKim MDSohn IKShim SHJon DISeo JSShin YCMin KJYoon BHBahk WMDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2015, Iss default, Pp 493-506 (2015)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Woo YS Lee JG Jeong JH Kim MD Sohn IK Shim SH Jon DI Seo JS Shin YC Min KJ Yoon BH Bahk WM Korean Medication Algorithm Project for Bipolar Disorder: third revision
description	Young Sup Woo,1 Jung Goo Lee,2,3 Jong-Hyun Jeong,1 Moon-Doo Kim,4 Inki Sohn,5 Se-Hoon Shim,6 Duk-In Jon,7 Jeong Seok Seo,8 Young-Chul Shin,9 Kyung Joon Min,10 Bo-Hyun Yoon,11 Won-Myong Bahk1 1Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, South Korea; 2Department of Psychiatry, Inje University Haeundae Paik Hospital, Busan, South Korea;3Paik Institute for Clinical Research, Inje Univeristy, Busan, South Korea; 4Department of Psychiatry, Jeju National University Hospital, Jeju, South Korea; 5Department of Psychiatry, Keyo Hospital, Keyo Medical Foundation, Uiwang, South Korea; 6Department of Psychiatry, Soonchunhyang University Cheonan Hospital, Soonchunhyang University, Cheonan, South Korea; 7Department of Psychiatry, Sacred Heart Hospital, Hallym University, Anyang, South Korea; 8Department of Psychiatry, School of Medicine, Konkuk University, Chungju, South Korea; 9Department of Psychiatry, Kangbuk Samsung Hospital, School of Medicine, Sungkyunkwan University, Seoul, South Korea; 10Department of Psychiatry, College of Medicine, Chung-Ang University, Seoul, South Korea; 11Department of Psychiatry, Naju National Hospital, Naju, South Korea Objective: To constitute the third revision of the guidelines for the treatment of bipolar disorder issued by the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP 2014). Methods: A 56-item questionnaire was used to obtain the consensus of experts regarding pharmacological treatment strategies for the various phases of bipolar disorder and for special populations. The review committee included 110 Korean psychiatrists and 38 experts for child and adolescent psychiatry. Of the committee members, 64 general psychiatrists and 23 child and adolescent psychiatrists responded to the survey. Results: The treatment of choice (TOC) for euphoric, mixed, and psychotic mania was the combination of a mood stabilizer (MS) and an atypical antipsychotic (AAP); the TOC for acute mild depression was monotherapy with MS or AAP; and the TOC for moderate or severe depression was MS plus AAP/antidepressant. The first-line maintenance treatment following mania or depression was MS monotherapy or MS plus AAP; the first-line treatment after mania was AAP monotherapy; and the first-line treatment after depression was lamotrigine (LTG) monotherapy, LTG plus MS/AAP, or MS plus AAP plus LTG. The first-line treatment strategy for mania in children and adolescents was MS plus AAP or AAP monotherapy. For geriatric bipolar patients, the TOC for mania was AAP/MS monotherapy, and the TOC for depression was AAP plus MS or AAP monotherapy. Conclusion: The expert consensus in the KMAP-BP 2014 differed from that in previous publications; most notably, the preference for AAP was increased in the treatment of acute mania, depression, and maintenance treatment. There was increased expert preference for the use of AAP and LTG. The major limitation of the present study is that it was based on the consensus of Korean experts rather than on experimental evidence. Keywords: pharmacological treatment, treatment guideline, expert consensus
format	article
author	Woo YS Lee JG Jeong JH Kim MD Sohn IK Shim SH Jon DI Seo JS Shin YC Min KJ Yoon BH Bahk WM
author_facet	Woo YS Lee JG Jeong JH Kim MD Sohn IK Shim SH Jon DI Seo JS Shin YC Min KJ Yoon BH Bahk WM
author_sort	Woo YS
title	Korean Medication Algorithm Project for Bipolar Disorder: third revision
title_short	Korean Medication Algorithm Project for Bipolar Disorder: third revision
title_full	Korean Medication Algorithm Project for Bipolar Disorder: third revision
title_fullStr	Korean Medication Algorithm Project for Bipolar Disorder: third revision
title_full_unstemmed	Korean Medication Algorithm Project for Bipolar Disorder: third revision
title_sort	korean medication algorithm project for bipolar disorder: third revision
publisher	Dove Medical Press
publishDate	2015
url	https://doaj.org/article/20ebf0a4880c45368fd2c5d1fccf8833
work_keys_str_mv	AT wooys koreanmedicationalgorithmprojectforbipolardisorderthirdrevision AT leejg koreanmedicationalgorithmprojectforbipolardisorderthirdrevision AT jeongjh koreanmedicationalgorithmprojectforbipolardisorderthirdrevision AT kimmd koreanmedicationalgorithmprojectforbipolardisorderthirdrevision AT sohnik koreanmedicationalgorithmprojectforbipolardisorderthirdrevision AT shimsh koreanmedicationalgorithmprojectforbipolardisorderthirdrevision AT jondi koreanmedicationalgorithmprojectforbipolardisorderthirdrevision AT seojs koreanmedicationalgorithmprojectforbipolardisorderthirdrevision AT shinyc koreanmedicationalgorithmprojectforbipolardisorderthirdrevision AT minkj koreanmedicationalgorithmprojectforbipolardisorderthirdrevision AT yoonbh koreanmedicationalgorithmprojectforbipolardisorderthirdrevision AT bahkwm koreanmedicationalgorithmprojectforbipolardisorderthirdrevision
_version_	1718401781408464896

Korean Medication Algorithm Project for Bipolar Disorder: third revision

Ejemplares similares